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Institute for Medical Research, Addenbrooke’s Hospital, Cambridge, United KingdomABSTRACT There is evidence that polycystin-2 (TRPP2) interacts with two other members of the transient receptor potential
(TRP) family, TRPC1 and TRPV4. We have previously shown that TRPP2 forms a heteromeric complex with TRPC1, with a 2:2
stoichiometry and an alternating subunit arrangement. Here, we used coimmunoprecipitation to show that TRPP2 also interacts
with TRPV4, but not with TRPA1 or TRPM8; hence, its promiscuity is limited. We then used atomic force microscopy to study the
structure of the TRPV4 homomer and the interaction between TRPP2 and TRPV4. The molecular volume of V5-tagged TRPV4
isolated from singly-transfected tsA 201 cells indicated that it assembled as a homotetramer. The distribution of angles between
pairs of anti-V5 antibodies bound to TRPV4 particles had a large peak close to 90 and a smaller peak close to 180, again
consistent with the assembly of TRPV4 as a homotetramer. In contrast, the angle distributions for decoration of the TRPP2-
TRPV4 heteromer by either anti-Myc or anti-V5 antibodies had major peaks close to 180. This result indicates that TRPP2-
TRPV4 assembles identically to TRPP2-TRPC1, suggesting a common subunit arrangement among heteromeric TRP channels.INTRODUCTIONPolycystin-2 (TRPP2) is a member of the transient receptor
potential (TRP) channel superfamily (1), and has a role in
regulating Ca2þ efflux from the endoplasmic reticulum
(2,3). Importantly, it also interacts with polycystin-1 to
form a Ca2þ-permeable ion channel complex (4). This
complex transduces extracellular mechanical stimuli via
the renal primary cilium (5), and regulates multiple intracel-
lular Ca2þ-sensitive signaling pathways (4,6). Mutations in
TRPP2 and polycystin-1 underlie autosomal dominant poly-
cystic kidney disease (ADPKD), one of the commonest
inherited human disorders (reviewed in (7,8)). ADPKD has
a population prevalence of over 1:1000 in all ethnic groups,
and is a major cause of end-stage renal failure. It is charac-
terized by the progressive development of multiple fluid-
filled cysts derived from renal tubular epithelial cells.
In addition to its interaction with polycystin-1, TRPP2 is
known to interact with other members of the TRP super-
family, such as TRPC1 (9,10) and TRPV4 (11), and to coloc-
alize with both of these proteins at the primary cilium
(10,11). We have recently shown that TRPP2 and TRPC1
form a heterotetramer with a 2:2 stoichiometry and an alter-
nating subunit arrangement (12). The architecture of the
TRPP2-TRPC1 heteromer was determined using a method
based on atomic force microscopy (AFM) imaging
(13–15). The method involves engineering specific epitope
tags, including His6, onto each subunit and expressing the
proteins in a suitable cell line (e.g., tsA 201). Crude
membrane fractions from the transfected cells are solubilized
in detergent, and the proteins are isolated through binding to
Ni2þ-agarose beads. The proteins are incubated with anti-Submitted March 20, 2010, and accepted for publication May 6, 2010.
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0006-3495/10/08/0790/8 $2.00bodies to the tags, and the resulting multimer-antibody
complexes are imaged by AFM. Multimers with two bound
antibodies are identified, and the angles between the anti-
bodies are measured. A frequency distribution of these
angles then reveals the architecture of the multimer.
In this study, we used coimmunoprecipitation to determine
the extent of TRPP2’s interactions with other members of the
TRP channel superfamily. We found that TRPP2 interacts
with TRPC1 and TRPV4, as previously demonstrated
(9–12), but not with TRPA1 and TRPM8; hence, its promis-
cuity is limited.We then usedAFM imaging to study the inter-
action of TRPP2 with TRPV4. We show that, as with TRPP2
and TRPC1, TRPP2 and TRPV4 form a heterotetramer with
a 2:2 stoichiometry and an alternating subunit arrangement.MATERIALS AND METHODS
Cell culture
tsA 201 cells (a subclone of human embryonic kidney-293 cells stably
expressing the SV40 large T-antigen) were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% (v/v) fetal calf serum, 100 units/mL
penicillin, and 100 mg/mL streptomycin, in an atmosphere of 5% CO2/air.Channel constructs
DNA encoding human TRPP2 was subcloned into the pcDNA3.1/Myc-His
vector (Invitrogen, Paisley, UK), which produces a protein tagged at its
C-terminus with Myc and His6 epitopes. In addition, the sequence encoding
the His6 tag was deleted from this construct to enable the expression of
a protein containing only the Myc epitope. DNA for mouse TRPV4, human
TRPC1, rat TRPA1, and rat TRPM8, all tagged at their C-termini with V5
and His6 epitopes, were expressed in the pcDNA3.1/V5-His-TOPO vector
(Invitrogen). The TRPV4, TRPA1, and TRPM8 constructs were a kind
gift of Dr. Xuming Zhang (Department of Pharmacology, University of
Cambridge).doi: 10.1016/j.bpj.2010.05.012
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Transient transfections of tsA 201 cells with DNA were carried out using the
CalPhos mammalian transfection kit (Clontech, Basingstoke, UK), accord-
ing to the manufacturer’s instructions. A total of 250 mg of DNA was
used to transfect cells in 5 162 cm2 culture flasks. When cells were doubly
transfected, 125 mg of DNA for each construct was used. After transfection,
cells were incubated for 24–48 h at 37C, to allow protein expression.
Protein expression and intracellular localization were checked using
immunofluorescence analysis of small-scale cultures. Cells were fixed,
permeabilized, and incubated with appropriate primary antibodies (mouse
monoclonal anti-Myc and anti-V5, from Invitrogen; mouse monoclonal
anti-HA, from Covance, Basel, Switzerland; rabbit polyclonal anti-Myc,
from Abcam, Cambridge, UK), followed by either Cy3- or fluorescein iso-
thiocyanate-conjugated goat secondary antibodies (Sigma-Aldrich, Poole,
UK). Cells were imaged by confocal laser scanning microscopy.Coimmunoprecipitation of TRPP2 with other
members of the TRP channel superfamily
TRPP2 was coexpressed with TRPC1, TRPV4, TRPA1, or TRPM8 by
transient transfection of tsA 201 cells. TRPP2 was immunoprecipitated
using a rabbit polyclonal anti-Myc antibody, and its partner protein was
immunoprecipitated using a mouse monoclonal anti-V5 antibody. A mouse
monoclonal anti-HA antibody was used as a negative control. Immunopre-
cipitates were analyzed by SDS-polyacrylamide gel electrophoresis fol-
lowed by immunoblotting, using mouse monoclonal anti-Myc or anti-V5
antibodies.Solubilization and puriﬁcation of His6-tagged
proteins
The solubilization/purification procedure was as described previously (13).
Briefly, a crude membrane fraction prepared from the cells was solubilized
in 1% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate,
and the solubilized material was incubated with Ni2þ-agarose beads
(Probond, Invitrogen). The beads were washed extensively, and bound
proteins were eluted with increasing concentrations of imidazole. Samples
were analyzed by SDS-polyacrylamide gel electrophoresis, and proteins
were detected by immunoblotting, using mouse monoclonal antibodies
against Myc (TRPP2) or V5 (TRPV4), or a rabbit polyclonal antibody
against His6 (TRPP2 and TRPV4; Research Diagnostics, Flanders, NJ).FIGURE 1 Expression of TRP channels in tsA 201 cells. (A) Cells were
transiently transfected with DNA encoding Myc/His6-tagged TRPP2 or
V5/His6-tagged TRPV4, TRPC1, TRPA1, or TRPM8. Cells were fixed,
permeabilized, and incubated with mouse monoclonal anti-Myc, anti-V5,
or anti-HA (control) antibodies, followed by Cy3-conjugated goat anti-
mouse secondary antibody. Cells were imaged by confocal laser scanning
microscopy. (B) Cells were doubly transfected with TRPP2-Myc/His6 in
addition to V5/His6-tagged TRPV4, TRPC1, TRPA1, or TRPM8. Cells
were fixed, permeabilized, and incubated with rabbit polyclonal anti-Myc
or mouse monoclonal anti-V5 antibodies, followed by Cy3-conjugated
goat anti-rabbit or fluorescein isothiocyanate-conjugated goat anti-mouse
secondary antibodies. As shown, the anti-Myc and anti-V5 signals exten-
sively overlapped, indicating that the majority of transfected cells expressed
both TRPP2 and its partner protein.AFM imaging of TRP proteins and TRP-antibody
complexes
Isolated channels were imaged either alone or after overnight incubation at
4C with a 1:2 molar ratio (~0.2 nM channel protein concentration) of anti-
epitope tag monoclonal antibody (Invitrogen). Proteins were diluted to a final
concentration of 0.04 nM, and 45 mL of the sample was allowed to adsorb to
freshly cleaved, poly-L-lysine-coated mica disks. After a 5-min incubation,
the sample was washed with BPC-grade water (Sigma-Aldrich) and dried
under nitrogen. Imaging was performed with a Multimode atomic force
microscope controlled by a Nanoscope IIIa controller (Veeco Digital Instru-
ments, Santa Barbara, CA). Samples were imaged in air, using tapping
mode. The silicon cantilevers used had a drive frequency ~300 kHz and
a specified spring constant of 40 N/m (Olympus, Tokyo, Japan). The applied
imaging force was kept as low as possible (As/A0 ~ 0.85).
The molecular volumes of the protein particles were determined from
particle dimensions based on AFM images. After adsorption of the channels
onto the mica support, the particles adopt the shape of a spherical cap. As
described previously (13), the heights and radii were measured from
multiple cross-sections of the same particle, and the molecular volume
was calculated using the equationVm ¼ ðph=6Þ

3r2 þ h2; (1)
where h is the particle height and r is the radius.
Molecular volume based on molecular mass was calculated using the
equation
Vc ¼ ðM0=N0ÞðV1 þ dV2Þ; (2)
whereM0 is the molecular mass, N0 is Avogadro’s number, V1 and V2 are the
partial specific volumes of particle (0.74 cm3/g) and water (1 cm3/g), respec-
tively, and d is the extent of protein hydration (taken as 0.4 gwater/g protein).RESULTS
The tsA 201 cells were transiently transfected with DNA en-
coding Myc/His6-tagged TRPP2 or V5/His6-tagged TRPC1,
TRPV4, TRPA1, or TRPM8. Protein expression and
localization was confirmed by immunofluorescence, using
appropriate anti-tag antibodies. The staining signals with
either anti-Myc or anti-V5 antibodies showed the expression
of all five channels (Fig. 1 A, left-hand and center panels).
In contrast, use of an anti-HA antibody as a negative control
produced only background immunofluorescence signals
(Fig. 1 A, right-hand panels). Bright-field imaging indicated
that in all cases the tsA 201 cells were confluent (data not
shown); hence, the transfection efficiency was 20–30%.Biophysical Journal 99(3) 790–797
FIGURE 2 Coimmunoprecipitation of TRPP2 with other members of the
TRP channel superfamily. TRPP2 was coexpressed with TRPC1, TRPV4,
TRPA1, or TRPM8 by transient transfection of tsA 201 cells. Crude
membrane fractions prepared from the cells were solubilized in 1% CHAPS.
TRPP2 was immunoprecipitated using a rabbit polyclonal anti-Myc
antibody, and its partner protein was immunoprecipitated using a mouse
monoclonal anti-V5 antibody. A mouse monoclonal anti-HA antibody
was used as a negative control. Immunoprecipitates were analyzed by
SDS-polyacrylamide gel electrophoresis followed by immunoblotting using
mouse monoclonal anti-Myc or anti-V5 antibodies. Immunoreactive bands
were visualized using enhanced chemiluminescence.
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V5/His6-tagged TRPC1, TRPV4, TRPA1, or TRPM8 gave
positive immunofluorescence signals with both anti-Myc
and anti-V5 antibodies, indicating the presence of the pairs
of proteins (Fig. 1 B). As shown, the anti-Myc and anti-V5
signals in doubly-labeled cell populations extensively over-
lapped, indicating that the majority of transfected cells
expressed both TRPP2 and its partner protein. Singly trans-
fected cells were seen occasionally, indicating that cross-talk
between the fluorescent signals was minimal. The reticular
staining patterns suggest that all five channels were localized
predominantly in the endoplasmic reticulum.
Crude membrane fractions prepared from cells expressing
TRPP2-Myc/His6 in addition to V5/His6-tagged TRPC1,
TRPV4, TRPA1, or TRPM8 were solubilized in CHAPS
detergent (1% w/v). Fractions were then incubated with
anti-Myc, anti-V5 or anti-HA (control) antibodies, followed
by immunoprecipitation using Protein G-Sepharose. Precip-
itated samples were subjected to SDS-polyacrylamide gel
electrophoresis and immunoblotting using either anti-Myc
or anti-V5 antibodies. As shown in Fig. 2, TRPP2 coprecipi-
tated with either TRPC1 or TRPV4, but not with TRPA1 or
TRPM8. Coprecipitation of TRPP2 with TRPC1 and TRPV4
is consistent with previous reports that these pairs of proteins
interact (9–12). Lack of coprecipitation with TRPA1 and
TRPM8 indicates that its interactions within the TRP
channel superfamily are not completely promiscuous.
Membrane fractions from cells expressing TRPV4-
V5/His6, or both TRPP2-Myc/His6 and TRPV4-V5/His6,
were solubilized in 1% CHAPS and proteins were isolated
through the binding of the His6 tags to Ni
2þ-agarose beads.
Isolated proteins were immunoblotted with anti-Myc, anti-
V5, or anti-His6 antibodies. In a fraction from cells express-
ing TRPV4, the anti-V5 antibody labeled a band at 100 kDa,
consistent with the expected size of the TRPV4 subunit, with
its epitope tags (Fig. 3 A). In a fraction from cells expressing
both TRPP2 and TRPV4, the anti-V5 antibody detected the
same 100-kDa band (TRPV4), and the anti-Myc antibody
labeled a band at 110 kDa, consistent with the expected
size of epitope-tagged TRPP2 (Fig. 3 B). The anti-His6 anti-
body labeled bands at both 100 kDa and 110 kDa in a fraction
from the cotransfected cells (Fig. 3 B). Hence, the Ni2þ-
agarose beads successfully captured the appropriate proteins
from the transfected cells. Note that on the anti-His6 immu-
noblot, the signal was stronger for TRPP2 than for TRPV4.
Assuming that the His6 tags on the two subunits are equally
accessible to the anti-His6 antibody, this result indicates that
the isolated fraction contains more TRPP2 than TRPV4.
Proteins isolated from cells expressing TRPV4 and
TRPP2-TRPV4 were imaged by AFM. A representative
low-magnification AFM image of a sample isolated from
TRPV4-expressing cells is shown in Fig. 3 C. The image
shows a population of relatively large particles, indicating
the presence of a predominant protein species. A similar
image was obtained from samples prepared from TRPP2-Biophysical Journal 99(3) 790–797TRPV4-expressing cells (data not shown). Frequency distri-
butions of molecular volumes were produced for the two sets
of particles (Fig. 3, D and E). The mean molecular volumes
were 9765 13 (SE) nm3 (n ¼ 998) for TRPV4 (Fig. 3 D),
and 8835 14 nm3 (n ¼ 991) for TRPP2-TRPV4 (Fig. 3 E).
The molecular volumes predicted for the TRPV4 and TRPP2
subunits on the basis of their molecular mass are 190 nm3
and 209 nm3, respectively; hence, a TRPV4 homotetramer
would have a predicted molecular volume of 760 nm3,
whereas a TRPP2-TRPV4 heterotetramer would have a pre-
dicted molecular volume in the range 779–817 nm3, depend-
ing on the subunit stoichiometry (i.e., 1:3, 2:2, or 3:1). The
measured volumes of both TRPV4 and TRPP2-TRPV4,
therefore, are consistent with a tetrameric structure, as
already demonstrated for TRPC1, TRPP2, and TRPP2-
TRPC1 (12). It should be pointed out, though, that measure-
ment of molecular volumes by AFM is complicated by
factors such as the convolution introduced by the geometry
of the scanning tip. Hence, the measured volume is not by
itself a reliable indicator of the stoichiometry of the channel.
FIGURE 3 Isolation and AFM imaging of
TRPV4 homomers and TRPP2-TRPV4 hetero-
mers. (A and B) Detection of proteins in samples
from cells expressing either TRPV4 alone (A) or
both TRPP2 and TRPV4 (B) eluted from Ni2þ-
agarose columns. Samples were analyzed by
SDS-polyacrylamide gel electrophoresis and
immunoblotting using anti-tag antibodies, followed
by horseradish peroxidase-conjugated goat
secondary antibodies. The total yield of isolated
proteins was ~500 ng, of which 30 ng was loaded
on the gels. (Arrowheads) Molecular-mass markers
(kDa). (C) Low-magnification AFM image of
proteins isolated from TRPV4-expressing cells.
(Right) Shade-height scale. (D and E) Frequency
distributions of molecular volumes of proteins iso-
lated from cells expressing TRPV4 (D) and
TRPP2-TRPV4 (E). (Curves) Fitted Gaussian func-
tions. The means of the distributions (5 SE) are
indicated.
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nels, they were imaged after antibody decoration. TRPV4
was imaged after incubation with anti-V5 antibody (of the
immunoglobulin G class), which should decorate the
C-terminal V5 epitope tag present on each subunit. A low-
magnification AFM image of TRPV4-antibody complexes
is shown in Fig. 4 A. Several large particles can be seen,
some of which have been decorated by either one (arrow-
head) or two (arrows) smaller particles. The small particles
had a molecular volume of ~220 nm3, close to the expected
volume of 285 nm3 for an immunoglobulin G molecule, of
molecular mass 150 kDa. Hence, these particles represent
anti-V5 antibodies bound to the V5 epitopes on the
TRPV4 channel. A gallery of undecorated, singly-, and
doubly-decorated large particles is shown in Fig. 4 B, along
with an example of a triply-decorated large particle. Of 1156
large particles imaged, 713 (61.7%) were undecorated, 369
(31.9%) were singly-decorated, 72 (6.2%) were doubly-de-
corated, and 2 (0.2%) were triply-decorated. No quadruply
decorated channels were seen. This antibody decoration
profile is similar to that predicted by the binomial distribu-
tion for an 11% occupancy of all potential binding sites
(calculated assuming that the channel is a tetramer).
We identified TRPV4 channels that had been decorated by
two or three antibodies and thenmeasured the angles between
the bound antibodies. This was done in each case by joining
the highest point on the central particle (the TRPV4 channel)
to the highest points on the peripheral particles (the anti-
bodies) by lines and then determining the angle between the
two lines. The frequency distribution of angles obtained isshown in Fig. 4 C. The angle distribution has two peaks: a
large peak at 985 2 and a smaller peak at 1765 14. The
ratio of the numbers of particles within the two peaks is 1.9:1.
For a homotetramer, the expected result is a distribution with
peaks at 90 and 180 in the ratio 2:1, close to the observed
ratio. In contrast, a trimer would give a single angle peak at
120 (13), whereas a pentamerwould give equally sized peaks
at 72 and 144 (15). Hence, the antibody decoration profile
confirms that TRPV4 assembles as a homotetramer.
When proteins isolated from cells expressing both
TRPP2-Myc/His6 and TRPV4-V5/His6 were incubated
with anti-Myc or anti-V5 antibodies and then imaged by
AFM, antibody-decorated large particles were again seen.
A gallery of zoomed images of undecorated particles, and
particles that had been singly- or doubly-decorated by either
anti-Myc or anti-V5 antibodies, is shown in Fig. 5 A. Of
1752 large particles imaged, 47 (2.7%) were doubly deco-
rated by anti-Myc antibodies. Similarly, of 1821 large parti-
cles imaged, 56 (3.1%) were doubly-decorated by anti-V5
antibodies. No triply or quadruply decorated particles were
seen for either anti-Myc or anti-V5 antibodies.
The angles between the pairs of bound antibodies were
measured and used to construct frequency distributions. As
for the TRPV4 homomer, both distributions had two peaks
(Fig. 5 B). However, in marked contrast to the results for
the homomer, the smaller peak was at 835 2 for anti-Myc
and 87 5 3 for anti-V5, whereas the larger peak was at
1635 2 for anti-Myc and 1755 11 for anti-V5. The ratios
of the numbers of particles within the two peakswere 1:1.8 for
anti-Myc and 1:2.3 for anti-V5. These distributions showBiophysical Journal 99(3) 790–797
FIGURE 4 Decoration of TRPV4 channels with anti-Myc antibodies.
(A) Low-magnification AFM images of a sample of isolated TRPV4 that
had been incubated with anti-Myc antibodies. (Arrowhead) Singly-deco-
rated TRPV4 particle. (Arrows) Doubly-decorated particles. (Right)
Shade-height scale. (B) Gallery of zoomed images of TRPV4 particles
that are undecorated (top), or decorated by one (middle) or two (bottom)
peripheral particles (antibodies). One triply decorated particle is also shown.
Angles between pairs of antibodies are indicated. (Right) Shade-height scale.
(C) Frequency distribution of angles between pairs of bound antibodies. The
curve indicates the fitted Gaussian functions. The peaks of the distribution
are indicated.
FIGURE 5 Decoration of TRPP2-TRPV4 channels with anti-Myc and
anti-V5 antibodies. (A) Gallery of zoomed images of particles that are undec-
orated (top), decorated by one or two anti-Myc antibodies (middle), or deco-
rated by one or two anti-V5 antibodies (bottom). Angles between pairs of
antibodies are indicated. (Right) Shade-height scale. (B) Frequency distribu-
tions of angles between pairs of bound anti-Myc and anti-V5 antibodies. The
curves indicate the fitted Gaussian functions. The peaks of the distributions
are indicated. (C) (Diagram) Predominant subunit arrangement within the
TRPP2-TRPV4 heteromer, as revealed by the antibody decoration patterns.
794 Stewart et al.a strong preference for decoration of the TRPP2-TRPV4 het-
eromer at ~180, indicating a predominantly alternating
subunit arrangement, as illustrated in Fig. 4 C.
The TRPP2-TRPV4 heteromer showed small antibody
decoration peaks at 90, for both Myc and V5 epitope tags.
These peaks could result from the isolation of minor popula-
tions of TRPP2 and TRPV4 homomers from the TRPP2-Biophysical Journal 99(3) 790–797TRPV4-transfected cells. This is especially likely for
TRPP2, because the anti-His6 antibody immunoblot
(Fig. 3 B) suggested that the protein fraction prepared from
cotransfected cells contained more TRPP2 than TRPV4.
Structure of the TRPP2/TRPV4 Heteromer 795Alternatively, they could indicate that the architecture of the
heteromer is not invariant, and that some of the heteromers
assemble with a TRPP2-TRPP2-TRPV4-TRPV4 arrange-
ment. To distinguish between these two possibilities, we ex-
pressed a combination of TRPP2-Myc (lacking a His6 tag)
and TRPV4-V5/His6 in the tsA 201 cells. The normal isola-
tion procedure was then used to produce protein complexes
containing TRPV4-V5/His6. Isolated proteins were then
incubated with anti-Myc antibodies, which would decorate
only heteromeric complexes containing TRPP2-Myc. Of
2047 large particles imaged, 48 (2.3%) were doubly deco-
rated by anti-Myc antibodies. In a control experiment, we
incubated the isolated channels with anti-HA antibody.
Now only 0.4% of the large particles were doubly decorated;
hence, the vast majority of the double decoration events seen
with anti-Myc were specific. A gallery of protein complexes
doubly decorated with anti-Myc is shown in Fig. 6 A. All the
angles were now ~180. Gaussian fitting showed that the
frequency distribution of angles between pairs of bound anti-
bodies (Fig. 6 B) had only a single peak, at 161 5 5
(n ¼ 48); the peak at ~90 seen previously was not present.
This result indicates that the heteromer assembles with the
exclusive subunit arrangement TRPP2-TRPV4-TRPP2-
TRPV4, and that the 90 peak was a result of the presence
of a minority of homotetramers in the isolates from cells
expressing both TRPP2-Myc/His6 and TRPV4-V5/His6.FIGURE 6 Decoration of TRPP2-TRPV4 channels isolated from cells ex-
pressing TRPP2-Myc and TRPV4-V5/His6 with anti-Myc antibodies. (A)
Gallery of zoomed images of particles decorated by two anti-Myc anti-
bodies. Angles between pairs of antibodies are indicated. (Right) Shade-
height scale. (B) Frequency distributions of angles between pairs of bound
anti-Myc antibodies. (Curve) Fitted Gaussian function. The peak of the
distribution is indicated. (C) (Diagram) Subunit arrangement within the
TRPP2-TRPV4 heteromer, as revealed by the antibody decoration pattern.DISCUSSION
TRPP2 has been shown previously to interact with both
TRPC1 (9,10) and TRPV4 (11). These interactions have
been detected by coimmunoprecipitation and fluorescence
resonance energy transfer, and through the demonstration
that coexpression of two different subunits produces
channels with properties distinct from those formed after
expression of either subunit alone. TRPP2 and TRPV4 are
coexpressed at the primary cilium of renal epithelial cells,
and the two proteins form a mechano- and thermosensor
(11). Depletion of TRPV4 abolishes flow-induced Ca2þ tran-
sients, suggesting that the two proteins are key components
of the ciliary mechanosensor. Significantly, however,
TRPV4-deficient zebrafish and TRPV4 knockout mice do
not develop cysts, suggesting that the TRPP2-TRPV4
complex is not involved in the etiology of ADPKD. This
is not to say that TRPV4 is completely uninvolved in cystic
disease, as cholangiocyte hyperproliferation can be reduced
in a mouse model of autosomal recessive polycystic kidney
disease using TRPV4 agonists (16).
In this study, we have confirmed the observations that
TRPP2 coimmunoprecipitates with TRPC1 and TRPV4.
In addition, we show that the promiscuity of TRPP2’s interac-
tions is limited; for instance, it does not interact with represen-
tatives of the TRPA and TRPM channel families. This
selectivity has also been reported for members of the TRPC
family, where TRPC1 interacts with TRPC4 and 5, andTRPC3, 6 and 7 are also able to form heteromers, whereas
TRPC2 only forms homomers (17). The structural basis of
these selective interactions is so far obscure. The interaction
between TRPP2 and TRPC1 was mapped to two regions of
TRPP2: the cytosolic C-terminus, and a larger region
including transmembrane regions 2–6 and the connecting
loops (9). However, why TRPP2 interacts with TRPC1 and
TRPV4 but not with TRPA1 or TRPM8 is not known.Biophysical Journal 99(3) 790–797
796 Stewart et al.Several techniques, including cryo-electron microscopy,
fluorescence resonance energy transfer and chemical
cross-linking have been used to show that various TRP
channels, including TRPC1 (14), TRPC3 (18), TRPV1
(19,20), TRPV5 and TRPV6 (21), and TRPM2 (22)
assemble as tetramers. Here we used antibody decoration
of epitopes on TRPV4 subunits to demonstrate that
TRPV4, too, forms homotetramers. This result is in agree-
ment with the recent findings of Shigematsu et al. (23) using
cryo-EM. As far as we are aware, the only exceptions to this
pattern of tetrameric assembly of TRP channels are the recent
reports of a trimeric structure for TRPP2, based in part on the
behavior of isolated C-terminal fragments (24,25). These
results conflict with our demonstration, again based on anti-
body decoration, that TRPP2, like the other channels listed
above, is tetrameric (12).
Although we used equal amounts of DNA for the two
constructs when expressing the TRPP2/TRPV4 heteromer,
the isolated fraction apparently contained more TRPP2 than
TRPV4. Nevertheless, the heteromer assembled with a 2:2
stoichiometry and alternating subunit arrangement, suggest-
ing that this arrangementmight be the preferred assembly state
for the heteromeric channel. This suggestion is supported by
our recent demonstration that TRPP2 also assembles with
TRPC1 to form a heteromeric channel with alternating
subunits (12). As yet, however, we cannot exclude the possi-
bility that the subunit stoichiometry of the heteromer is not
fixed, but rather can be manipulated by changing the relative
expression levels of the two subunits, as we have previously
found for the P2X2/P2X6 receptor heteromer (26).
We are now in a position to test the generality of our
proposed model for the assembly of heteromeric TRP chan-
nels by applying our AFM-based method to other pairs of
interacting subunits. It should also be possible to use muta-
tional analysis to determine the regions responsible for the
apparent preferential interactions between different subunits,
such as TRPP2 and TRPV4. Clinical mutations affecting ho-
momeric and heteromeric assembly of TRPP2 have been
identified. These include a truncation of the C-terminal tail
of TRPP2 that triggers its interaction with TRPC3 and
TRPC7 (27). Using our AFM-based approach, we ought to
be able to begin to understand the molecular mechanisms
underlying the assembly of TRP channel heteromers. Of
most relevance to the etiology of ADPKD, of course, is the
interaction of TRPP2 with polycystin-1. We hope that
AFM imaging might also allow us to determine the architec-
ture of the complex formed between these two proteins.We thank Dr. Xuming Zhang for providing the TRPV4, TRPA1, and
TRPM8 expression vectors.
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